Клинические исследование Cardiovascular Risk: Ziltivekimab, Placebo (ziltivekimab)

Спонсоры	Ведущий спонсор: Novo Nordisk A/S
Источник	Novo Nordisk A/S
Краткое содержание	This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation. Participants will either get ziltivekimab (active medicine) or placebo (a dummy medicine which has no effect on the body). This is known as the study medicine. Which treatment participants get is decided by chance. Participants chance of getting ziltivekimab or placebo is the same. Ziltivekimab is not yet approved in any country or region in the world. It is a new medicine doctors cannot prescribe. Participants will get the study medicine in a pre filled syringe. Participants will need to use the pre filled syringe to inject the study medicine into a skinfold once-monthly. The study is expected to last for up to 4 years. Participants will have up to 20 clinic visits. Participants will have blood and urine samples taken at most of the clinic visits. Participants will have their heart examined using sound waves (echocardiography) and electrodes (electrocardiogram). Women cannot take part if pregnant, breast-feeding or planning to get pregnant during the study period.

Общий статус

Recruiting

Дата начала

2021-08-30

Дата завершения

2025-10-15

Дата первичного завершения

2025-09-24

Фаза

Phase 3

Тип исследования

Interventional

Первичный результат

Мера	Временное ограничение
Time to first occurrence of 3-point major adverse cardiovascular event (MACE), a composite endpoint consisting of: Cardiovascular (CV ) death (Based on EAC-confirmed events; including undetermined cause of death)	From randomisation (month 0) to end-of-study (up to 48 months)
Time to first occurrence of 3-point MACE, a composite endpoint consisting of: non-fatal myocardial infarction(MI) ( Based on EAC-confirmed events; including undetermined cause of death; acute MI only)	From randomisation (month 0) to end-of-study (up to 48 months)
Time to first occurrence of 3-point MACE, a composite endpoint consisting of: non-fatal stroke (Based on EAC-confirmed events; including ischaemic, haemorrhagic and undetermined stroke)	From randomisation (month 0) to end-of-study (up to 48 months)

Вторичный результат

Мера	Временное ограничение
Time to first occurrence of expanded MACE, a composite endpoint consisting of: CV death (Based on EAC-confirmed events; including undetermined cause of death	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to first occurrence of expanded MACE, a composite endpoint consisting of: non-fatal MI (Based on EAC-confirmed events; acute MI only)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to first occurrence of expanded MACE, a composite endpoint consisting of: non-fatal stroke (Based on EAC-confirmed events; including ischaemic, haemorrhagic and undetermined stroke)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to first occurrence of expanded MACE, a composite endpoint consisting of: hospitalisation for unstable angina pectoris requiring urgent coronary revascularisation (Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Number of hospitalisations for heart failure (Based on EAC-confirmed events) or urgent heart failure visit (Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months) (Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to occurrence of all-cause mortality (Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months) (Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to first occurrence of a composite CKD endpoint consisting of:onset of persistent greater than or equal to 40% reduction in eGFR (CKD-EPI) compared with baseline	From randomisation (month 0) to end-of-study (up to 48 months) (Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to first occurrence of a composite CKD endpoint consisting of kidney failure defined as:death from kidney failure	From randomisation (month 0) to end-of-study (up to 48 months) (Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to first occurrence of a composite CKD endpoint consisting of:kidney failure defined as onset of persistente eGFR below 15 mL/min/1.73 m^2 (CKD-EPI)	From randomisation (month 0) to end-of-study (up to 48 months) (Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to first occurrence of a composite CKD endpoint consisting of: initiation of chronic kidney replacement therapy (maintenance dialysis or kidney transplantation (Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months) (Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-month follow-up period)
Time to first occurrence of each of the individual components (Based on EAC-confirmed events) of the expanded MACE endpoint and the kidney composite endpoint	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of MIs (acute MI only) (fatal and non-fatal) (Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of stroke (including ischaemic, haemorrhagic and undetermined stroke) (fatal and non-fatal)(Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of a composite MACE endpoint consisting of:all-cause mortality (Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of a composite MACE endpoint consisting of:non-fatal MI (Based on EAC-confirmed events; acute MI only)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of a composite MACE endpoint consisting of:non-fatal stroke (Based on EAC-confirmed events,including ischaemic, haemorrhagic and undetermined stroke)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of an expanded composite kidney endpoint consisting of:CV death (Based on EAC-confirmed events; including undetermined cause of death)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of an expanded composite kidney endpoint consisting of:onset of persistent greater than or equal to 40% reduction in eGFR (CKD-EPI) compared with baseline	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of an expanded composite kidney endpoint consisting of:kidney failure defined as:death from kidney failure	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of an expanded composite kidney endpoint consisting of:kidney failure defined as onset of persistent eGFR below 15 mL/min/1.73 m^2 (CKD-EPI)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of an expanded composite kidney endpoint consisting of:kidney failure defined as:initiation of chronic kidney replacement therapy (maintenance dialysis or kidney transplantation) (Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Time to first occurrence of coronary revascularisation	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Change in UACR (urinary albumin-to-creatinine ratio )	From randomisation (month 0) to 2 years (24 months)
Change in eGFR (estimated glomerular filtration rate) (chronic kidney disease - epidemiology collaboration (CKD-EPI))	From randomisation (month 0) to 2 years (24 months)
Annual rate of change in eGFR (CKD-EPI) (total eGFR slope)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Change in high-sensitivity C-reactive protein (hs-CRP)	From randomisation (month 0) to 2 years (24 months
Change in N-terminal-pro-brain natriuretic peptide ( NT-pro-BNP)	From randomisation (month 0) to 2 years (24 months)
Change in left ventricular ejection fraction (LVEF)	From randomisation (month 0) to 2 years (24 months)
Number of events of atrial fibrillation	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Number of hospitalisations with infection as primary cause (Based on EAC-confirmed events) or death due to infection (Based on EAC-confirmed events)	From randomisation (month 0) to end-of-study (up to 48 months)(Maximum treatment duration is dependent on event rates and is estimated to be approximately 48 months including a 3-months follow-up period;)
Change in Short Form 36 (SF-36) Physical Component Score (PCS)	From randomisation (month 0) to 2 years (24 months)

Регистрация

6200

Состояние	Cardiovascular Risk Chronic Kidney Disease Inflammation
Вмешательство	Тип вмешательства: Drug Название вмешательства: Ziltivekimab Описание: Administered subcutaneously (s.c., under skin) once-monthly and added to standard of care Этикетка Arm Group: ziltivekimab 15 mg Тип вмешательства: Drug Название вмешательства: Placebo (ziltivekimab) Описание: Administered subcutaneously (s.c., under skin) once-monthly and added to standard of care Этикетка Arm Group: Placebo (ziltivekimab)
Приемлемость	Критерии: Inclusion Criteria: - Estimated glomerular filtration rate (eGFR) 15 and below 60 mL/min/1.73 m^2 (using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation) - Serum high-sensitivity C-reactive protein (hs-CRP) greater than or equal to 2 mg/L at screening (visit 1) - Evidence of atherosclerotic cardiovascular disease (ASCVD) by one or more of the following within the last 5 years from screening: a) Coronary heart disease defined as at least one of the following: i. Documented history of MI ii. Prior coronary revascularisation procedure iii. greater than or equal to 50% stenosis in major epicardial coronary artery documented by cardiac catheterisation or CT coronary angiography b) Cerebrovascular disease defined as at least one of the following: i. Prior stroke of atherosclerotic origin ii. Prior carotid artery revascularisation procedure iii. greater than or equal to 50% stenosis in carotid artery documented by X-ray angiography, MR angiography, CT angiography or Doppler ultrasound. c) Symptomatic peripheral artery disease (PAD) defined as at least one of the following: i. Intermittent claudication with an ankle-brachial index (ABI) below or equal to 0.90 at rest ii. Intermittent claudication with a greater than or equal to 50% stenosis in peripheral artery (excluding carotid) documented by X-ray angiography, MR angiography, CT angiography or Doppler ultrasound iii. Prior peripheral artery (excluding carotid) revascularisation procedure iv. Lower extremity amputation at or above ankle due to atherosclerotic disease (excluding e.g. trauma or osteomyelitis). Exclusion Criteria: - Clinical evidence of, or suspicion of, active infection at the discretion of the investigator. - Myocardial infarction, stroke, hospitalisation for unstable angina pectoris, or transient ischaemic attack within 60 days prior to randomisation (visit 2). - Planned coronary, carotid or peripheral artery revascularisation known on the day of screening (visit 1). - Major cardiac surgical, non-cardiac surgical, or major endoscopic procedure (thoracoscopic or laparoscopic) within the past 60 days prior to randomisation (visit 2) or any major surgical procedure planned at the time of randomisation (visit 2). Пол: All Минимальный возраст: 18 Years Максимальный возраст: N/A Здоровые волонтеры: No

Состояние

Cardiovascular Risk
Chronic Kidney Disease
Inflammation

Вмешательство

Тип вмешательства: Drug

Название вмешательства: Ziltivekimab

Описание: Administered subcutaneously (s.c., under skin) once-monthly and added to standard of care

Этикетка Arm Group: ziltivekimab 15 mg

Тип вмешательства: Drug

Название вмешательства: Placebo (ziltivekimab)

Описание: Administered subcutaneously (s.c., under skin) once-monthly and added to standard of care

Этикетка Arm Group: Placebo (ziltivekimab)

Приемлемость

Критерии:

Inclusion Criteria: - Estimated glomerular filtration rate (eGFR) 15 and below 60 mL/min/1.73 m^2 (using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) creatinine equation) - Serum high-sensitivity C-reactive protein (hs-CRP) greater than or equal to 2 mg/L at screening (visit 1) - Evidence of atherosclerotic cardiovascular disease (ASCVD) by one or more of the following within the last 5 years from screening: a) Coronary heart disease defined as at least one of the following: i. Documented history of MI ii. Prior coronary revascularisation procedure iii. greater than or equal to 50% stenosis in major epicardial coronary artery documented by cardiac catheterisation or CT coronary angiography b) Cerebrovascular disease defined as at least one of the following: i. Prior stroke of atherosclerotic origin ii. Prior carotid artery revascularisation procedure iii. greater than or equal to 50% stenosis in carotid artery documented by X-ray angiography, MR angiography, CT angiography or Doppler ultrasound. c) Symptomatic peripheral artery disease (PAD) defined as at least one of the following: i. Intermittent claudication with an ankle-brachial index (ABI) below or equal to 0.90 at rest ii. Intermittent claudication with a greater than or equal to 50% stenosis in peripheral artery (excluding carotid) documented by X-ray angiography, MR angiography, CT angiography or Doppler ultrasound iii. Prior peripheral artery (excluding carotid) revascularisation procedure iv. Lower extremity amputation at or above ankle due to atherosclerotic disease (excluding e.g. trauma or osteomyelitis). Exclusion Criteria: - Clinical evidence of, or suspicion of, active infection at the discretion of the investigator. - Myocardial infarction, stroke, hospitalisation for unstable angina pectoris, or transient ischaemic attack within 60 days prior to randomisation (visit 2). - Planned coronary, carotid or peripheral artery revascularisation known on the day of screening (visit 1). - Major cardiac surgical, non-cardiac surgical, or major endoscopic procedure (thoracoscopic or laparoscopic) within the past 60 days prior to randomisation (visit 2) or any major surgical procedure planned at the time of randomisation (visit 2).

Пол:

All

Минимальный возраст:

18 Years

Максимальный возраст:

N/A

Здоровые волонтеры:

Общий Официальный

Фамилия	Роль	Присоединение
Clinical Transparency (dept. 1452)	Study Director	Novo Nordisk A/S

Общий контакт

Фамилия: Novo Nordisk

Телефон: (+1) 866-867-7178

Расположение

Объект:	Положение дел:
Novo Nordisk Investigational Site \| Birmingham, Alabama, 35294, United States	Recruiting
Novo Nordisk Investigational Site \| Montgomery, Alabama, 36106, United States	Recruiting
Novo Nordisk Investigational Site \| Glendale, Arizona, 85308, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Mesa, Arizona, 85210, United States	Recruiting
Novo Nordisk Investigational Site \| Searcy, Arkansas, 72143, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Covina, California, 91723, United States	Recruiting
Novo Nordisk Investigational Site \| La Jolla, California, 92037, United States	Not yet recruiting
Novo Nordisk Investigational Site \| La Mesa, California, 91942, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Lancaster, California, 93534, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Los Alamitos, California, 90720, United States	Recruiting
Novo Nordisk Investigational Site \| Lynwood, California, 90262, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Northridge, California, 91325, United States	Recruiting
Novo Nordisk Investigational Site \| Palm Springs, California, 92262, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Riverside, California, 92503, United States	Not yet recruiting
Novo Nordisk Investigational Site \| S. Gate, California, 90280, United States	Not yet recruiting
Novo Nordisk Investigational Site \| San Dimas, California, 91773, United States	Recruiting
Novo Nordisk Investigational Site \| Torrance, California, 90502, United States	Recruiting
Novo Nordisk Investigational Site \| Bridgeport, Connecticut, 06610, United States	Not yet recruiting
Novo Nordisk Investigational Site \| West Haven, Connecticut, 06516, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Boca Raton, Florida, 33434, United States	Recruiting
Novo Nordisk Investigational Site \| Boynton Beach, Florida, 33437, United States	Recruiting
Novo Nordisk Investigational Site \| Clearwater, Florida, 33756, United States	Recruiting
Novo Nordisk Investigational Site \| Fleming Island, Florida, 32003, United States	Recruiting
Novo Nordisk Investigational Site \| Hollywood, Florida, 33021, United States	Recruiting
Novo Nordisk Investigational Site \| Jacksonville, Florida, 32204, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Miami Lakes, Florida, 33014, United States	Recruiting
Novo Nordisk Investigational Site \| Miami, Florida, 33126, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Miami, Florida, 33130, United States	Recruiting
Novo Nordisk Investigational Site \| Miami, Florida, 33155, United States	Not yet recruiting
Novo Nordisk Investigational Site \| New Port Richey, Florida, 34652, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Palm Harbor, Florida, 34684, United States	Recruiting
Novo Nordisk Investigational Site \| Pembroke Pines, Florida, 33024, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Pembroke Pines, Florida, 33027, United States	Recruiting
Novo Nordisk Investigational Site \| Port Charlotte, Florida, 33952, United States	Recruiting
Novo Nordisk Investigational Site \| Port Charlotte, Florida, 33952, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Saint Augustine, Florida, 32080, United States	Recruiting
Novo Nordisk Investigational Site \| Saint Augustine, Florida, 32086, United States	Recruiting
Novo Nordisk Investigational Site \| Winter Haven, Florida, 33880, United States	Recruiting
Novo Nordisk Investigational Site \| Augusta, Georgia, 30904, United States	Recruiting
Novo Nordisk Investigational Site \| Conyers, Georgia, 30094, United States	Recruiting
Novo Nordisk Investigational Site \| Johns Creek, Georgia, 30024, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Roswell, Georgia, 30076, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Savannah, Georgia, 31406, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Nampa, Idaho, 83686-6011, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Arlington Heights, Illinois, 60005, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Gurnee, Illinois, 60031, United States	Recruiting
Novo Nordisk Investigational Site \| Hazel Crest, Illinois, 60429, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Skokie, Illinois, 60077, United States	Recruiting
Novo Nordisk Investigational Site \| Springfield, Illinois, 62711, United States	Recruiting
Novo Nordisk Investigational Site \| Wauconda, Illinois, 60084, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Evansville, Indiana, 47714, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Valparaiso, Indiana, 46383, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Overland Park, Kansas, 66211, United States	Recruiting
Novo Nordisk Investigational Site \| Topeka, Kansas, 66606, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Lexington, Kentucky, 40503, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Louisville, Kentucky, 40205, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Bossier City, Louisiana, 71111, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Monroe, Louisiana, 71201, United States	Recruiting
Novo Nordisk Investigational Site \| Slidell, Louisiana, 70458, United States	Recruiting
Novo Nordisk Investigational Site \| West Monroe, Louisiana, 71201, United States	Recruiting
Novo Nordisk Investigational Site \| Annapolis, Maryland, 21401, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Bethesda, Maryland, 20814, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Camp Springs, Maryland, 20746, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Boston, Massachusetts, 02115-5804, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Haverhill, Massachusetts, 01830, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Detroit, Michigan, 48202, United States	Recruiting
Novo Nordisk Investigational Site \| Flint, Michigan, 48532, United States	Recruiting
Novo Nordisk Investigational Site \| Grand Rapids, Michigan, 49546, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Minneapolis, Minnesota, 55407, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Kansas City, Missouri, 64111, United States	Recruiting
Novo Nordisk Investigational Site \| Saint Louis, Missouri, 63128, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Saint Louis, Missouri, 63136, United States	Recruiting
Novo Nordisk Investigational Site \| Lincoln, Nebraska, 68526, United States	Recruiting
Novo Nordisk Investigational Site \| Omaha, Nebraska, 68105, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Omaha, Nebraska, 68114, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Omaha, Nebraska, 68198-3020, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Las Vegas, Nevada, 89128, United States	Recruiting
Novo Nordisk Investigational Site \| Bridgewater, New Jersey, 08807-3064, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Northport, New York, 11768, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Ridgewood, New York, 11385, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Saratoga Springs, New York, 12866, United States	Not yet recruiting
Novo Nordisk Investigational Site \| West Seneca, New York, 14224, United States	Recruiting
Novo Nordisk Investigational Site \| Westfield, New York, 14787, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Asheville, North Carolina, 28801, United States	Recruiting
Novo Nordisk Investigational Site \| Burlington, North Carolina, 27215, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Chapel Hill, North Carolina, 27599, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Charlotte, North Carolina, 28207, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Greensboro, North Carolina, 27408, United States	Recruiting
Novo Nordisk Investigational Site \| Greenville, North Carolina, 27834, United States	Recruiting
Novo Nordisk Investigational Site \| Morehead City, North Carolina, 28557-4346, United States	Recruiting
Novo Nordisk Investigational Site \| Fargo, North Dakota, 58104, United States	Recruiting
Novo Nordisk Investigational Site \| Cleveland, Ohio, 44106, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Maumee, Ohio, 43537, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Bethlehem, Pennsylvania, 18017, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Philadelphia, Pennsylvania, 19114, United States	Recruiting
Novo Nordisk Investigational Site \| Philadelphia, Pennsylvania, 19144, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Lincoln, Rhode Island, 02865, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Fort Mill, South Carolina, 29707, United States	Recruiting
Novo Nordisk Investigational Site \| Greenville, South Carolina, 29615, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Myrtle Beach, South Carolina, 29588, United States	Suspended
Novo Nordisk Investigational Site \| Spartanburg, South Carolina, 29303, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Chattanooga, Tennessee, 37411, United States	Recruiting
Novo Nordisk Investigational Site \| Greeneville, Tennessee, 37745, United States	Recruiting
Novo Nordisk Investigational Site \| Knoxville, Tennessee, 37934, United States	Recruiting
Novo Nordisk Investigational Site \| Memphis, Tennessee, 38119, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Arlington, Texas, 76012-4637, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Corpus Christi, Texas, 78414, United States	Recruiting
Novo Nordisk Investigational Site \| Dallas, Texas, 75208, United States	Recruiting
Novo Nordisk Investigational Site \| Dallas, Texas, 75230, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Dallas, Texas, 75235, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Edinburg, Texas, 78539, United States	Not yet recruiting
Novo Nordisk Investigational Site \| El Paso, Texas, 79935, United States	Recruiting
Novo Nordisk Investigational Site \| Forney, Texas, 75126, United States	Recruiting
Novo Nordisk Investigational Site \| Fort Worth, Texas, 76132, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Fort Worth, Texas, 76133, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Houston, Texas, 77024, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Houston, Texas, 77043, United States	Recruiting
Novo Nordisk Investigational Site \| Houston, Texas, 77054, United States	Recruiting
Novo Nordisk Investigational Site \| Houston, Texas, 77079, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Houston, Texas, 77084, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Houston, Texas, 77090, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Live Oak, Texas, 78233, United States	Recruiting
Novo Nordisk Investigational Site \| Longview, Texas, 75605, United States	Recruiting
Novo Nordisk Investigational Site \| Lufkin, Texas, 75904, United States	Recruiting
Novo Nordisk Investigational Site \| San Antonio, Texas, 78212, United States	Recruiting
Novo Nordisk Investigational Site \| San Antonio, Texas, 78215, United States	Recruiting
Novo Nordisk Investigational Site \| San Antonio, Texas, 78224, United States	Not yet recruiting
Novo Nordisk Investigational Site \| San Antonio, Texas, 78230, United States	Recruiting
Novo Nordisk Investigational Site \| San Marcos, Texas, 78666, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Sugar Land, Texas, 77478, United States	Recruiting
Novo Nordisk Investigational Site \| Waco, Texas, 76708, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Webster, Texas, 77598, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Forest, Virginia, 24551, United States	Not yet recruiting
Novo Nordisk Investigational Site \| Norfolk, Virginia, 23510-2015, United States	Recruiting
Novo Nordisk Investigational Site \| Salem, Virginia, 24153-6404, United States	Recruiting
Novo Nordisk Investigational Site \| Winchester, Virginia, 22601-3834, United States	Recruiting
Novo Nordisk Investigational Site \| Wausau, Wisconsin, 54401, United States	Recruiting
Novo Nordisk Investigational Site \| Buenos Aires, B6000BHA, Argentina	Not yet recruiting
Novo Nordisk Investigational Site \| Caba, C1213, Argentina	Not yet recruiting
Novo Nordisk Investigational Site \| Caba, C1428ART, Argentina	Not yet recruiting
Novo Nordisk Investigational Site \| Caba, C1440CFD, Argentina	Recruiting
Novo Nordisk Investigational Site \| Ciudad Autónoma de Buenos Aire, 1425, Argentina	Recruiting
Novo Nordisk Investigational Site \| Mar del Plata, B7600GNY, Argentina	Not yet recruiting
Novo Nordisk Investigational Site \| Quilmes - Buenos Aires, B1878DVB, Argentina	Not yet recruiting
Novo Nordisk Investigational Site \| San Nicolás, B2900, Argentina	Not yet recruiting
Novo Nordisk Investigational Site \| Garran, Australian Capital Territory, 2605, Australia	Recruiting
Novo Nordisk Investigational Site \| Gosford, New South Wales, 2250, Australia	Recruiting
Novo Nordisk Investigational Site \| Milton, Queensland, 4064, Australia	Recruiting
Novo Nordisk Investigational Site \| Adelaide, South Australia, 5000, Australia	Not yet recruiting
Novo Nordisk Investigational Site \| Clayton, Victoria, 3168, Australia	Not yet recruiting
Novo Nordisk Investigational Site \| Fitzroy, Victoria, 3065, Australia	Not yet recruiting
Novo Nordisk Investigational Site \| Geelong, Victoria, 3220, Australia	Not yet recruiting
Novo Nordisk Investigational Site \| Joondalup, Western Australia, 6027, Australia	Recruiting
Novo Nordisk Investigational Site \| Aalst, 9300, Belgium	Not yet recruiting
Novo Nordisk Investigational Site \| Brasschaat, 2930, Belgium	Not yet recruiting
Novo Nordisk Investigational Site \| Brugge, 8000, Belgium	Recruiting
Novo Nordisk Investigational Site \| Genk, 3600, Belgium	Recruiting
Novo Nordisk Investigational Site \| Kortrijk, 8500, Belgium	Recruiting
Novo Nordisk Investigational Site \| Liège, 4000, Belgium	Not yet recruiting
Novo Nordisk Investigational Site \| Mechelen, 2800, Belgium	Not yet recruiting
Novo Nordisk Investigational Site \| Curitiba, Parana, 80440-020, Brazil	Not yet recruiting
Novo Nordisk Investigational Site \| Pleven, 5800, Bulgaria	Recruiting
Novo Nordisk Investigational Site \| Plovdiv, 4002, Bulgaria	Not yet recruiting
Novo Nordisk Investigational Site \| Sofia, 1309, Bulgaria	Recruiting
Novo Nordisk Investigational Site \| Sofia, 1407, Bulgaria	Not yet recruiting
Novo Nordisk Investigational Site \| Sofia, 1431, Bulgaria	Recruiting
Novo Nordisk Investigational Site \| Sofia, 1431, Bulgaria	Not yet recruiting
Novo Nordisk Investigational Site \| Sofia, 1527, Bulgaria	Not yet recruiting
Novo Nordisk Investigational Site \| Sofia, 1750, Bulgaria	Not yet recruiting
Novo Nordisk Investigational Site \| Sofia, 1750, Bulgaria	Recruiting
Novo Nordisk Investigational Site \| Varna, 9010, Bulgaria	Not yet recruiting
Novo Nordisk Investigational Site \| Calgary, Alberta, T2H 2G4, Canada	Recruiting
Novo Nordisk Investigational Site \| Calgary, Alberta, T2V 4J2, Canada	Recruiting
Novo Nordisk Investigational Site \| Vancouver, British Columbia, V5Y 3W2, Canada	Recruiting
Novo Nordisk Investigational Site \| Halifax, Nova Scotia, B3H 2Y9, Canada	Not yet recruiting
Novo Nordisk Investigational Site \| Barrie, Ontario, L4N 7L3, Canada	Recruiting
Novo Nordisk Investigational Site \| Brampton, Ontario, L6S 0C6, Canada	Recruiting
Novo Nordisk Investigational Site \| Concord, Ontario, L4K 4M2, Canada	Recruiting
Novo Nordisk Investigational Site \| Etobicoke, Ontario, M9R 4E1, Canada	Recruiting
Novo Nordisk Investigational Site \| Hamilton, Ontario, L8M 1K7, Canada	Recruiting
Novo Nordisk Investigational Site \| Nepean, Ontario, K2J 0V2, Canada	Recruiting
Novo Nordisk Investigational Site \| North York, Ontario, M6B 3H7, Canada	Recruiting
Novo Nordisk Investigational Site \| Oakville, Ontario, L6K 3W7, Canada	Not yet recruiting
Novo Nordisk Investigational Site \| Oakville, Ontario, L6M 1M1, Canada	Recruiting
Novo Nordisk Investigational Site \| Peterborough, Ontario, K9J 0B2, Canada	Not yet recruiting
Novo Nordisk Investigational Site \| Scarborough, Ontario, M1B 4Z8, Canada	Not yet recruiting
Novo Nordisk Investigational Site \| Toronto, Ontario, M4G 3E8, Canada	Recruiting
Novo Nordisk Investigational Site \| Toronto, Ontario, M6G 1M2, Canada	Not yet recruiting
Novo Nordisk Investigational Site \| Waterloo, Ontario, N2T 0C1, Canada	Not yet recruiting
Novo Nordisk Investigational Site \| Brossard, Quebec, J4Z-2K9, Canada	Recruiting
Novo Nordisk Investigational Site \| Laval, Quebec, H7T 2P5, Canada	Recruiting
Novo Nordisk Investigational Site \| Quebec, G1G 3Y8, Canada	Not yet recruiting
Novo Nordisk Investigational Site \| Beijing, Beijing, 100853, China	Not yet recruiting
Novo Nordisk Investigational Site \| Aarhus N, 8200, Denmark	Not yet recruiting
Novo Nordisk Investigational Site \| Herning, 7400, Denmark	Recruiting
Novo Nordisk Investigational Site \| Hvidovre, 2650, Denmark	Recruiting
Novo Nordisk Investigational Site \| Svendborg, 5700, Denmark	Recruiting
Novo Nordisk Investigational Site \| Aachen, 52074, Germany	Not yet recruiting
Novo Nordisk Investigational Site \| Bad Homburg, 61348, Germany	Not yet recruiting
Novo Nordisk Investigational Site \| Dresden, 01277, Germany	Suspended
Novo Nordisk Investigational Site \| Düsseldorf, 40210, Germany	Not yet recruiting
Novo Nordisk Investigational Site \| Elsterwerda, 04910, Germany	Not yet recruiting
Novo Nordisk Investigational Site \| Essen, 45136, Germany	Recruiting
Novo Nordisk Investigational Site \| Falkensee, 14612, Germany	Not yet recruiting
Novo Nordisk Investigational Site \| Lübeck, 23562, Germany	Not yet recruiting
Novo Nordisk Investigational Site \| Oldenburg I. Holst, 23758, Germany	Recruiting
Novo Nordisk Investigational Site \| Witten, 58455, Germany	Suspended
Novo Nordisk Investigational Site \| Athens, 11527, Greece	Not yet recruiting
Novo Nordisk Investigational Site \| Athens, GR-11527, Greece	Not yet recruiting
Novo Nordisk Investigational Site \| Athens, GR-11528, Greece	Recruiting
Novo Nordisk Investigational Site \| Athens, GR-14233, Greece	Recruiting
Novo Nordisk Investigational Site \| Athens, GR-15123, Greece	Recruiting
Novo Nordisk Investigational Site \| Chios, GR82100, Greece	Recruiting
Novo Nordisk Investigational Site \| Haidari-Athens, GR-12462, Greece	Recruiting
Novo Nordisk Investigational Site \| Ioannina, 45500, Greece	Not yet recruiting
Novo Nordisk Investigational Site \| Kifissia, GR-14561, Greece	Recruiting
Novo Nordisk Investigational Site \| Lamia, GR35100, Greece	Not yet recruiting
Novo Nordisk Investigational Site \| Larissa, GR-41110, Greece	Recruiting
Novo Nordisk Investigational Site \| Patra, GR-26504, Greece	Recruiting
Novo Nordisk Investigational Site \| Thessaloniki, GR-57010, Greece	Not yet recruiting
Novo Nordisk Investigational Site \| Vijayawada, Andhra Pradesh, 520002, India	Recruiting
Novo Nordisk Investigational Site \| Mangalore, Karnataka, 575002, India	Recruiting
Novo Nordisk Investigational Site \| Manipal, Karnataka, 576104, India	Recruiting
Novo Nordisk Investigational Site \| Nagpur, Maharashtra, 440003, India	Recruiting
Novo Nordisk Investigational Site \| Hyderabad, Telengana, 500012, India	Recruiting
Novo Nordisk Investigational Site \| Belgaum, 590010, India	Recruiting
Novo Nordisk Investigational Site \| Holon, 58100, Israel	Recruiting
Novo Nordisk Investigational Site \| Jerusalem, 91120, Israel	Recruiting
Novo Nordisk Investigational Site \| Rehovot, 7661041, Israel	Recruiting
Novo Nordisk Investigational Site \| Tel Aviv, 6423906, Israel	Recruiting
Novo Nordisk Investigational Site \| Tel Hashomer, 5265601, Israel	Recruiting
Novo Nordisk Investigational Site \| Catanzaro, 88100, Italy	Not yet recruiting
Novo Nordisk Investigational Site \| Milano, 20138, Italy	Not yet recruiting
Novo Nordisk Investigational Site \| Milan, 20132, Italy	Not yet recruiting
Novo Nordisk Investigational Site \| Montichiari, 25018, Italy	Not yet recruiting
Novo Nordisk Investigational Site \| Rome, 00189, Italy	Recruiting
Novo Nordisk Investigational Site \| Verona, 37126, Italy	Recruiting
Novo Nordisk Investigational Site \| Bunkyo-ku, Tokyo, 113-8655, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Fukushima, 963-8851, Japan	Recruiting
Novo Nordisk Investigational Site \| Ibaraki, 311-0113, Japan	Recruiting
Novo Nordisk Investigational Site \| Kishiwada, Osaka, 596-0042, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Kita-azumi-gun, Nagano, 399-8695, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Kumamoto-shi, Kumamoto, 860-8556, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Kumamoto, 862-0976, Japan	Recruiting
Novo Nordisk Investigational Site \| Kusegun, Kyoto, 613-0034, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Kyoto-shi, Kyoto, 607-8062, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Kyoto-shi,Kyoto, 601-1495, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Matsudo-shi, 270-2251, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Meguro-ku, Tokyo, 153-0051, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Naha-shi, Okinawa, 902-8511, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Okayama, 701-0192, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Omihachiman-shi, Siga, 523-0082, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Osaka-shi, Osaka, 533-0024, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Osaka-shi,Osaka, 559-0012, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Sapporo-shi, Hokkaido, 062-0003, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Sendai-shi, Miyagi, 980-8574, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Takamatsu-shi, Kagawa, 760-8557, Japan	Recruiting
Novo Nordisk Investigational Site \| Yao-shi, Osaka, 581-0011, Japan	Not yet recruiting
Novo Nordisk Investigational Site \| Yonezawa-shi, Yamagata, 992-0045, Japan	Recruiting
Novo Nordisk Investigational Site \| Busan, 49201, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Busan, 49241, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Daegu, 42472, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Daegu, 42601, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Daejeon, 35015, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Gangwon-do, 26426, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Gwangju, 61469, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Gyeonggi-do, 13620, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Incheon, 21565, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Seoul, 02841, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Seoul, 03722, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Seoul, 05278, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Seoul, 08308, Korea, Republic of	Not yet recruiting
Novo Nordisk Investigational Site \| Kaunas, 48259, Lithuania	Not yet recruiting
Novo Nordisk Investigational Site \| Kaunas, 49449, Lithuania	Recruiting
Novo Nordisk Investigational Site \| Siauliai, 76231, Lithuania	Recruiting
Novo Nordisk Investigational Site \| Alor Setar, 05460, Malaysia	Recruiting
Novo Nordisk Investigational Site \| Ipoh, Perak, 30450, Malaysia	Not yet recruiting
Novo Nordisk Investigational Site \| Kedah, 08000, Malaysia	Recruiting
Novo Nordisk Investigational Site \| Kota Bharu, Kelantan, 16150, Malaysia	Recruiting
Novo Nordisk Investigational Site \| Kota Bharu, 15586, Malaysia	Not yet recruiting
Novo Nordisk Investigational Site \| Kota Samarahan, 94300, Malaysia	Recruiting
Novo Nordisk Investigational Site \| Kuala Lumpur, 59100, Malaysia	Not yet recruiting
Novo Nordisk Investigational Site \| Sabah, 88300, Malaysia	Recruiting
Novo Nordisk Investigational Site \| Seremban, 70300, Malaysia	Recruiting
Novo Nordisk Investigational Site \| Mexico City, México, D.F., 03300, Mexico	Recruiting
Novo Nordisk Investigational Site \| Monterrey, Nuevo León, 64020, Mexico	Recruiting
Novo Nordisk Investigational Site \| Monterrey, Nuevo León, 64060, Mexico	Not yet recruiting
Novo Nordisk Investigational Site \| Monterrey, Nuevo León, 64460, Mexico	Recruiting
Novo Nordisk Investigational Site \| San Luis Potosí, San Luis Potosi, 78200, Mexico	Recruiting
Novo Nordisk Investigational Site \| Culiacán, Sinaloa, 80230, Mexico	Recruiting
Novo Nordisk Investigational Site \| Aguascalientes, 20230, Mexico	Recruiting
Novo Nordisk Investigational Site \| Queretaro, 76000, Mexico	Recruiting
Novo Nordisk Investigational Site \| Veracruz, 91900, Mexico	Recruiting
Novo Nordisk Investigational Site \| Alkmaar, 1815 JD, Netherlands	Recruiting
Novo Nordisk Investigational Site \| Almelo, 7609 PP, Netherlands	Not yet recruiting
Novo Nordisk Investigational Site \| Amsterdam, 1105 AZ, Netherlands	Recruiting
Novo Nordisk Investigational Site \| Apeldoorn, 7334 DZ, Netherlands	Recruiting
Novo Nordisk Investigational Site \| Hilversum, 1213 XZ, Netherlands	Not yet recruiting
Novo Nordisk Investigational Site \| Rotterdam, 3083 AN, Netherlands	Recruiting
Novo Nordisk Investigational Site \| Sneek, 8601 ZR, Netherlands	Recruiting
Novo Nordisk Investigational Site \| Zaandam, 1502 DV, Netherlands	Not yet recruiting
Novo Nordisk Investigational Site \| Bialystok, 15-481, Poland	Not yet recruiting
Novo Nordisk Investigational Site \| Elblag, 82-300, Poland	Recruiting
Novo Nordisk Investigational Site \| Gorzow Wielkopolski, 66-400, Poland	Recruiting
Novo Nordisk Investigational Site \| Krakow, 30-082, Poland	Recruiting
Novo Nordisk Investigational Site \| Krakow, 31-209, Poland	Recruiting
Novo Nordisk Investigational Site \| Krakow, 31-261, Poland	Not yet recruiting
Novo Nordisk Investigational Site \| Kraków, 31-202, Poland	Recruiting
Novo Nordisk Investigational Site \| Lodz, 90-242, Poland	Recruiting
Novo Nordisk Investigational Site \| Lodz, 90-549, Poland	Recruiting
Novo Nordisk Investigational Site \| Lodz, 91-211, Poland	Recruiting
Novo Nordisk Investigational Site \| Pulawy, 24-100, Poland	Recruiting
Novo Nordisk Investigational Site \| Szczecin, 70-341, Poland	Recruiting
Novo Nordisk Investigational Site \| Warszawa, 04-628, Poland	Recruiting
Novo Nordisk Investigational Site \| Warszawa, 04-628, Poland	Not yet recruiting
Novo Nordisk Investigational Site \| Wroclaw, 51-162, Poland	Not yet recruiting
Novo Nordisk Investigational Site \| Zamosc, 22-400, Poland	Recruiting
Novo Nordisk Investigational Site \| Almada, 2805-267, Portugal	Not yet recruiting
Novo Nordisk Investigational Site \| Aveiro, 3814-501, Portugal	Not yet recruiting
Novo Nordisk Investigational Site \| Matosinhos, 4464-513, Portugal	Not yet recruiting
Novo Nordisk Investigational Site \| Novosibirsk, 630099, Russian Federation	Recruiting
Novo Nordisk Investigational Site \| Sochi, 354057, Russian Federation	Not yet recruiting
Novo Nordisk Investigational Site \| Bratislava, 81369, Slovakia	Recruiting
Novo Nordisk Investigational Site \| Bratislava, 83305, Slovakia	Not yet recruiting
Novo Nordisk Investigational Site \| Kosice, 040 01, Slovakia	Recruiting
Novo Nordisk Investigational Site \| Lubochna, 03491, Slovakia	Recruiting
Novo Nordisk Investigational Site \| Martin, 036 59, Slovakia	Suspended
Novo Nordisk Investigational Site \| Presov, 08-181, Slovakia	Not yet recruiting
Novo Nordisk Investigational Site \| Bloemfontein, Free State, 9301, South Africa	Not yet recruiting
Novo Nordisk Investigational Site \| Bloemfontein, Free State, 9301, South Africa	Recruiting
Novo Nordisk Investigational Site \| Centurion, Gauteng, 0157, South Africa	Recruiting
Novo Nordisk Investigational Site \| Johannesburg, Gauteng, 2013, South Africa	Not yet recruiting
Novo Nordisk Investigational Site \| Johannesburg, Gauteng, 2157, South Africa	Suspended
Novo Nordisk Investigational Site \| Johannesburg, Gauteng, 2193, South Africa	Recruiting
Novo Nordisk Investigational Site \| Pretoria, Gauteng, 0183, South Africa	Not yet recruiting
Novo Nordisk Investigational Site \| Pretoria, Gauteng, 0184, South Africa	Recruiting
Novo Nordisk Investigational Site \| Pretoria, Gauteng, 0186, South Africa	Not yet recruiting
Novo Nordisk Investigational Site \| Cape Town, Western Cape, 7130, South Africa	Recruiting
Novo Nordisk Investigational Site \| Cape Town, Western Cape, 7130, South Africa	Not yet recruiting
Novo Nordisk Investigational Site \| Cape Town, Western Cape, 7500, South Africa	Recruiting
Novo Nordisk Investigational Site \| Paarl, Western Cape, 7646, South Africa	Recruiting
Novo Nordisk Investigational Site \| Baracaldo, 48903, Spain	Not yet recruiting
Novo Nordisk Investigational Site \| Córdoba, 14004, Spain	Not yet recruiting
Novo Nordisk Investigational Site \| L' Hospitalet Del Llobregat, 08907, Spain	Not yet recruiting
Novo Nordisk Investigational Site \| Sanlúcar de Barrameda, 11540, Spain	Not yet recruiting
Novo Nordisk Investigational Site \| Valencia, 46010, Spain	Not yet recruiting
Novo Nordisk Investigational Site \| Valencia, 46017, Spain	Not yet recruiting
Novo Nordisk Investigational Site \| Zaragoza, 50009, Spain	Not yet recruiting
Novo Nordisk Investigational Site \| Malmö, 205 02, Sweden	Not yet recruiting
Novo Nordisk Investigational Site \| Stockholm, 141 85, Sweden	Not yet recruiting
Novo Nordisk Investigational Site \| Stockholm, 171 64, Sweden	Not yet recruiting
Novo Nordisk Investigational Site \| Hsinchu City, 300, Taiwan	Not yet recruiting
Novo Nordisk Investigational Site \| Tainan City, 704, Taiwan	Not yet recruiting
Novo Nordisk Investigational Site \| Taipei, 100, Taiwan	Not yet recruiting
Novo Nordisk Investigational Site \| Taipei, 112, Taiwan	Recruiting
Novo Nordisk Investigational Site \| Afyon, Turkey	Not yet recruiting
Novo Nordisk Investigational Site \| Ankara, 06230, Turkey	Recruiting
Novo Nordisk Investigational Site \| Antalya, 07058, Turkey	Recruiting
Novo Nordisk Investigational Site \| Eskisehir, 26040, Turkey	Recruiting
Novo Nordisk Investigational Site \| Istanbul, 34098, Turkey	Recruiting
Novo Nordisk Investigational Site \| Istanbul, 34098, Turkey	Not yet recruiting
Novo Nordisk Investigational Site \| Istanbul, 34381, Turkey	Not yet recruiting
Novo Nordisk Investigational Site \| Istanbul, 34668, Turkey	Not yet recruiting
Novo Nordisk Investigational Site \| Izmir, 35100, Turkey	Recruiting
Novo Nordisk Investigational Site \| Izmir, 35340, Turkey	Not yet recruiting
Novo Nordisk Investigational Site \| Kahramanmaras, 46040, Turkey	Not yet recruiting
Novo Nordisk Investigational Site \| Kayseri, 38039, Turkey	Recruiting
Novo Nordisk Investigational Site \| Kocaeli, 41380, Turkey	Recruiting
Novo Nordisk Investigational Site \| Mugla, 48000, Turkey	Not yet recruiting
Novo Nordisk Investigational Site \| Chernivtsi, 58023, Ukraine	Not yet recruiting
Novo Nordisk Investigational Site \| Ivano-Frankivsk, 76008, Ukraine	Not yet recruiting
Novo Nordisk Investigational Site \| Kharkiv, 61039, Ukraine	Not yet recruiting
Novo Nordisk Investigational Site \| Kharkiv, 61178, Ukraine	Not yet recruiting
Novo Nordisk Investigational Site \| Kyiv, 02091, Ukraine	Recruiting
Novo Nordisk Investigational Site \| Kyiv, 02660, Ukraine	Recruiting
Novo Nordisk Investigational Site \| Kyiv, 03037, Ukraine	Recruiting
Novo Nordisk Investigational Site \| Kyiv, 03049, Ukraine	Recruiting
Novo Nordisk Investigational Site \| Kyiv, 03151, Ukraine	Not yet recruiting
Novo Nordisk Investigational Site \| Kyiv, 03680, Ukraine	Not yet recruiting
Novo Nordisk Investigational Site \| Kyiv, 04050, Ukraine	Not yet recruiting
Novo Nordisk Investigational Site \| Kyiv, 04053, Ukraine	Not yet recruiting
Novo Nordisk Investigational Site \| Zaporizhzhia, 69063, Ukraine	Not yet recruiting 044 300-23-05 067 342-63-60 E-mail: info@luckytrials.com ИНФОРМАЦИЯ ПАЦИЕНТАМ О платформе О клинических исследованиях Соглашение о предоставлении информационно-посреднических услуг Права и обязанности участников Безопасность пациентов Список центров ema.europa.eu fda.gov who.int zakon.rada.gov.ua ПРАВОВАЯ ИНФОРМАЦИЯ Политика конфиденциальности Согласие на обработку персональных данных Пользовательское соглашение Специалистам Добавить анкету Войти Lucky Trials Copyright 2020 © ✖ Написать исследователям ✖ Хочу участвовать Мужчина Женщина ✖ Пришлите медицинские документы Возникли трудности с выбором? Необходима консультация? Оставь свои контакты и квалифицированный специалист с радостью поможет тебе. Выберите файл Файлы cookies Для персонализации сервисов мы используем файлы cookies. Продолжая использование сайта, вы соглашаетесь с этим. Подробности о файлах cookies и об обработке ваших данных — в Политике конфиденциальности.

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation